Dianthus Therapeutics, Inc. - Common Stock DNTH 深 沪
等待开盘 08-06 09:30:00 美东时间
21.71
+0.210
+0.98%
华盛通- 最 高22.01
- 今 开21.45
- 成交量 7.81万股
- 最 低 21.105
- 昨 收 21.50
- 总市值 6.98亿
- 52周最高 32.27
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 13.365
- 委 比 96.08%
- 总股本 3216.00万
- 历史最高 336.00
- 量 比 0.62
- 振 幅 4.21%
- 历史最低 5.136
- 每 手 1
- 风险率 3.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多William Blair Initiates Coverage On Dianthus Therapeutics with Outperform Rating
William Blair analyst Myles Minter initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Outperform rating.
07-03 03:01
Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference
纽约和马萨诸塞州沃尔瑟姆，2025年5月29日（全球新闻通讯社）——处于临床阶段的生物技术公司Dianthus Therapeutics, Inc.（纳斯达克：DNTH）宣布将参与杰富瑞全球医疗保健会议。公司首席执行官Marino Garcia将于6月5日（星期四）上午9:55（EDT）在纽约市进行炉边聊天，并与投资者举行一对一会议。投资者可登陆公司官网投资者版块观看直播。
05-29 11:00
美股大行评级 | 潜在涨幅158.9%！蒙特利尔银行上调Disc Medicine目标价至120美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1129333511617925121.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 蒙特利尔银行：维持Disc Medicine(IRON)"跑赢大市"评级，目标价从112美元升至120美元</p> <p>• 巴克莱：维持Karyopharm Therapeutics(KPTI)"超配"评级，目标价从5美
05-14 08:48
Breaking Down Dianthus Therapeutics: 5 Analysts Share Their Views
Across the recent three months, 5 analysts have shared their insights on Dianth...
05-13 21:01
HC Wainwright & Co. Reiterates Buy on Dianthus Therapeutics, Maintains $40 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Dianthus Therapeutics (NASDAQ:DNTH) with a Buy and maintains $40 price target.
05-13 18:56
Dianthus Therapeutics Q1 EPS $(0.82) Beats $(0.85) Estimate
Dianthus Therapeutics (NASDAQ:DNTH) reported quarterly losses of $(0.82) per share which beat the analyst consensus estimate of $(0.85) by 3.53 percent. This is a 51.85 percent decrease over losses of $(0.54) per share
05-13 04:34
美股大行评级 | 韦德布什：维持Astria Therapeutics(ATXS)"跑赢大市"评级，目标价从27美元升至28美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1106863358302064640.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 韦德布什：维持Astria Therapeutics(ATXS)"跑赢大市"评级，目标价从27美元升至28美元</p> <p>• HC Wainwright & Co.：维持LifeMD(LFMD)"买入"评级，目
03-13 09:38
Guggenheim Reiterates Buy on Dianthus Therapeutics, Maintains $84 Price Target
Guggenheim analyst Yatin Suneja reiterates Dianthus Therapeutics (NASDAQ:DNTH) with a Buy and maintains $84 price target.
03-12 21:53
Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
NEW YORK and WALTHAM, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Dianthus Therape...
01-08 20:00
Evaluating Dianthus Therapeutics: Insights From 5 Financial Analysts
Dianthus Therapeutics (NASDAQ:DNTH) has been analyzed by 5 analysts in the last...
2024-11-12 00:03
